Skip to main content
. 2017 Aug 4;8(40):68854–68862. doi: 10.18632/oncotarget.19924

Figure 3. Sensitivity analysis under specific model.

Figure 3

(A): effect of individual studies on the combined HR for OS with VEGFR1 rs9582036 (AA+AC vs CC); (B): effect of individual studies on the combined HR for OS with VEGFR1 rs9554320 (CC+AC vs AA).